COCHLEAR AMERICAS

Cochlear Americas is a leading manufacturer of implantable hearing devices and bone conduction systems for patients with hearing loss and hearing impairment. The company designs, manufactures, and distributes three primary product families: Cochlear Nucleus implant systems for sensorineural hearing loss, the Cochlear Osia bone conduction hearing system for conductive and mixed hearing loss, and the Cochlear Baha bone conduction systems. These devices serve adult and pediatric populations across the spectrum of hearing loss severity. Cochlear's product portfolio includes surgically implanted components and external sound processors with advanced signal processing, wireless connectivity, and audio streaming capabilities. The company supports both direct surgical implant recipients and hearing healthcare professionals including audiologists and otolaryngologists. Products are FDA-cleared and CE-marked for the European market. Cochlear operates a comprehensive service and support infrastructure including patient support programs, clinical training for implant surgeons and audiologists, accessory sales, and remote device management capabilities. The organization serves hospital systems, surgical centers, private audiology practices, and individual patients across North America.